https://doi.org/10.15252/emmm.201910880
S
Sang‐Yeob Kim
Ulsan College(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
2.4K
Citations
28
h-index
59
i10-index
Sang‐Yeob Kim is an academic researcher from Ulsan College. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune cells in cancer & Pancreatic and Hepatic Oncology Research. The author has an h-index of 28, co-authored 95 publications.
ORCID: 0000-0002-3724-256XPapers by this author
worksPhosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis
2019 · EMBO Molecular Medicine · 74 citations
Fecal microbiota transplantation ameliorates atherosclerosis in mice with C1q/TNF-related protein 9 genetic deficiency
2022 · Experimental & Molecular Medicine · 63 citations
https://doi.org/10.1038/s12276-022-00728-w
Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells
2019 · Experimental & Molecular Medicine · 60 citations
https://doi.org/10.1038/s12276-019-0268-5
Suppression of colitis‐associated carcinogenesis through modulation of IL‐6/STAT3 pathway by balsalazide and VSL#3
2015 · Journal of Gastroenterology and Hepatology · 52 citations
https://doi.org/10.1111/jgh.13280
Colorectal Cancer Diagnosis Using Enzyme‐Sensitive Ratiometric Fluorescence Dye and Antibody–Quantum Dot Conjugates for Multiplexed Detection
2017 · Advanced Functional Materials · 48 citations
https://doi.org/10.1002/adfm.201703450
Implication of CD69<sup>+</sup>CD103<sup>+</sup> tissue‐resident‐like CD8<sup>+</sup> T cells as a potential immunotherapeutic target for cholangiocarcinoma
2021 · Liver International · 48 citations
https://doi.org/10.1111/liv.14814
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat